Clinico-radiological Classification of Peritoneal Tuberculosis

Sponsor
Postgraduate Institute of Medical Education and Research (Other)
Overall Status
Completed
CT.gov ID
NCT03927664
Collaborator
(none)
55
2
15
27.5
1.8

Study Details

Study Description

Brief Summary

Traditionally, peritoneal tuberculosis has been classified as wet-ascitic, dry-plastic type and fibrotic -fixed types. there is substantial overlap between these definitions and the clinical implication of the categorisation into the three patterns is unclear.

The clinical presentation will be used to divide participants into 1) Abdominal distension dominant disease or 2) Pain Dominant and/or 3) Obstruction dominant peritoneal tuberculosis. The radiological findings between these groups will be compared if findings on radiology are discriminative of these three patterns of presentation.

Condition or Disease Intervention/Treatment Phase
  • Other: Radiological assessment

Detailed Description

The study will be conducted as two parts

  1. Derivation group:

Screening population: Patients with abdominal tuberculosis treated in the gastroenterology unit from Jan 2017-Dec 2018 This will involve a retrospective study where the patients who have been treated for peritoneal tuberculosis and have full records available (as hospital records or Gut-Tuberculosis clinic files) will be included and their clinical details and radiological findings (from CT films or images) will be entered and compared. The radiological findings between these groups will be compared if findings on radiology are discriminative of these three patterns of presentation.

  1. Validation Study: This will include prospective study of patients who have underwent computed tomography for evaluation of abdominal complaints and are eventually diagnosed to have peritoneal tuberculosis. The radiological parameters derived from the derivation group will be tested to predict the clinical presentation.

At the end of the study,the feasibility of a clinico-radiological classification of peritoneal tuberculosis.

The clinical details will be recorded and will include demographic details, diagnostic work-up (confirmed/probable), follow-up and classification into one of the three patterns of presentation

  1. Distension dominant: Presence of abdominal distention or discomfort, Lack of pain

  2. Pain dominant: Patients having associated significant abdominal pain necessitating analgesics or interfering with routine activities

  3. Obstruction dominant; Clear historical and/or radiological evidence of intestinal obstruction like abdominal pain associated with distension and obstipation

Computed tomographic scans/images will be assessed by the two radiologists separately and resolved by consensus The radiologists will not have access to any clinical details The findings will be recorded on a proforma and will include determination of presence and extent of ascites, loculated ascites, peritoneal nodules or masses, omental involvement as nodules or masses, mesenteric adenopathy, masses, abdominal lymphadenopathy, presence of clumped loops, adhesions, abdominal cocoon etc The three groups will be compared for these radiological patterns and a possible correlation between any radiological findings and the clinical presentation will be derived.

The classification derived from the derivation cohort will be tested in validation cohort which will be a prospective study. The clinical presentation will be recorded. The CT scans will be reviewed by two radiologists blinded to clinical details and the clinical presentation will be compared with categorisation based on the radiological findings.

Study Design

Study Type:
Observational
Actual Enrollment :
55 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Conception and Validation of a Clinico-radiological Classification of Peritoneal Tuberculosis
Actual Study Start Date :
May 1, 2019
Actual Primary Completion Date :
Apr 30, 2020
Actual Study Completion Date :
Jul 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Peritoneal Tuberculosis

Patients diagnosed with peritoneal tuberculosis and who have undergone a computed tomographic examination

Other: Radiological assessment
Radiological assessment of findings in the peritoneum, omentum, mesentery, ascites and other abdominal findings

Outcome Measures

Primary Outcome Measures

  1. Correlation of radiological characterization of classification with clinical presentation [3 months of diagnosis]

    Clinical presentation will be classified as 1) Distension dominant 2) Pain dominant 3) Obstruction dominant This will be correlated with the categorisation based on radiologic findings and correlation between the radiological category an actual clinical category will be studied

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • Patients diagnosed with peritoneal tuberculosis

  • Patients who have undergone a computed tomographic examination

Exclusion Criteria:
  • Age < 12

  • Unclear diagnosis

  • More than one etiology for ascites

  • Not willing for consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Postgraduate Institute of Medical Education and Research Chandigarh India 160036
2 Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh Chandigarh India

Sponsors and Collaborators

  • Postgraduate Institute of Medical Education and Research

Investigators

  • Principal Investigator: Vishal Sharma, Postgraduate Institute of Medical Education and Research

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Vishal Sharma, Assistant Professor, Postgraduate Institute of Medical Education and Research
ClinicalTrials.gov Identifier:
NCT03927664
Other Study ID Numbers:
  • NK/5243/Study/019
First Posted:
Apr 25, 2019
Last Update Posted:
Aug 31, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2020